The use of intensity-modulated proton therapy (IMPT) did not improve patient quality of life over the standard of care, intensity-modulated radiation therapy (IMRT), for the treatment of oropharyngeal ...
Intensity-modulated proton therapy (IMPT) matched intensity-modulated radiation therapy (IMRT) for progression-free survival in a phase III trial of oropharyngeal cancer. Patients receiving proton ...
According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved ...
According to preliminary data from a multi-institution Phase III trial intensity modulated proton therapy (IMPT) achieved similar clinical outcomes and offered significant patient benefits when ...
SAN FRANCISCO -- Treatment with intensity-modulated proton therapy (IMPT) or intensity-modulated radiation therapy (IMRT) resulted in similarly low rates of late toxicity in patients with locally ...
LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems, the leading global provider of compact proton therapy solutions, and RaySearch Laboratories AB, the market leader in software solutions for ...
Hosted on MSN
Proton therapy shows survival benefit in phase III trial for patients with head and neck cancers
A study published in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were treated with proton therapy (IMPT) compared to those treated with traditional ...
A new study offers hope for patients with recurrent lung cancer, who historically have been considered ineligible for curative treatment. In the largest analysis to date of reirradiation using ...
LITTLETON, Mass.--(BUSINESS WIRE)--RaySearch Laboratories AB (publ) and Mevion Medical Systems, two companies that are leading the field of proton therapy, announce a collaboration to develop advanced ...
At five years, 90.9% of proton patients were alive compared to 81% with traditional radiation Proton therapy also showed benefits in quality of life, such as less feeding tube dependence, less ...
CHICAGO ― According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results